Final EU guidance issued on clinical evaluation of coronary stents
This article was originally published in SRA
Final guidance from the European Commission on the clinical evaluation of coronary stents describes the main requirements for the clinical evaluation of this group of Class III medical devices based on current state-of-the-art and on experience drawn from the most recent reviews of clinical studies1.
You may also be interested in...
A report from the US FDA says the agency will focus on updating its premarket submission portal, training staff and taking additional steps to start taking in applications for ASCA pilot participant sponsors.
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.